These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1233 related items for PubMed ID: 30669789
1. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX. Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789 [Abstract] [Full Text] [Related]
2. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load? Aladag H, Aladag M. Eur Rev Med Pharmacol Sci; 2023 Mar 20; 27(5):2091-2098. PubMed ID: 36930508 [Abstract] [Full Text] [Related]
3. [Effects of tenofovir and telbivudine on HBV RNA in pregnant women with different genotypes of HBeAg-positive hepatitis B in Guizhou Province]. Zhang BF, Cheng ML, Lu S, Wu J, Wu YY, Liu Q, Zhao XK, Li YY, Hu YX, Liu W. Zhonghua Yi Xue Za Zhi; 2018 Nov 20; 98(43):3503-3508. PubMed ID: 30481899 [Abstract] [Full Text] [Related]
4. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus. Zhu B, Lv X, Zhao Z, Chen L, Chen X, Li C, Li S, Dai E. Medicine (Baltimore); 2021 Nov 05; 100(44):e27695. PubMed ID: 34871254 [Abstract] [Full Text] [Related]
5. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N. BMC Infect Dis; 2016 Aug 09; 16():393. PubMed ID: 27506549 [Abstract] [Full Text] [Related]
6. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice. Liu J, Wang J, Yan T, Du D, Qi C, Cao F, Yao N, Yang Y, He Y, Tian Z, Ren D, Zhu L, Chen T, Zhao Y. J Viral Hepat; 2019 Oct 09; 26(10):1170-1177. PubMed ID: 31177596 [Abstract] [Full Text] [Related]
7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N. N Engl J Med; 2018 Mar 08; 378(10):911-923. PubMed ID: 29514030 [Abstract] [Full Text] [Related]
8. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus]. Han GR, Jiang HX, Wang GJ, Yue X, Wang CM, Kan NY, Wu MM. Zhonghua Gan Zang Bing Za Zhi; 2012 Mar 08; 20(3):201-5. PubMed ID: 22475140 [Abstract] [Full Text] [Related]
9. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L. Vaccine; 2014 Oct 21; 32(46):6091-7. PubMed ID: 25240752 [Abstract] [Full Text] [Related]
10. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B. N Engl J Med; 2016 Jun 16; 374(24):2324-34. PubMed ID: 27305192 [Abstract] [Full Text] [Related]
11. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission]. Yin YZ, Zhou J, Zhang PZ, Hou HY. Zhonghua Gan Zang Bing Za Zhi; 2013 Feb 16; 21(2):105-10. PubMed ID: 23663881 [Abstract] [Full Text] [Related]
12. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Cochrane Database Syst Rev; 2017 Feb 11; 2(2):CD008545. PubMed ID: 28188612 [Abstract] [Full Text] [Related]
13. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection]. Guo HJ, Gao YF, Liu HY, He HT, Huang MT, Cai DC, Liao DD, Li JN, Yin XR, Liu ZH, Hu J. Zhonghua Gan Zang Bing Za Zhi; 2019 Feb 20; 27(2):112-117. PubMed ID: 30818915 [Abstract] [Full Text] [Related]
14. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study. Sheng QJ, Wang SJ, Wu YY, Dou XG, Ding Y. Medicine (Baltimore); 2018 Jun 20; 97(22):e10931. PubMed ID: 29851831 [Abstract] [Full Text] [Related]
15. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal]. Sheng QJ, Ding Y, Li BJ, Bai H, Zhang C, Han C, Fan YX, Li YW, Dou XG. Zhonghua Gan Zang Bing Za Zhi; 2016 Apr 20; 24(4):258-64. PubMed ID: 27470623 [Abstract] [Full Text] [Related]
16. Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis. Zhou J, Zhang P, Tan Z, Li C, Yao L, Han Z, Yin Y. BMC Infect Dis; 2024 Sep 11; 24(1):957. PubMed ID: 39261777 [Abstract] [Full Text] [Related]
17. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China. Sheng Q, Ding Y, Li B, Han C, Li Y, Zhang C, Bai H, Wang J, Zhao L, Xia T, An Z, Zhang M, Dou X. Int J Med Sci; 2018 Sep 11; 15(8):796-801. PubMed ID: 30008589 [Abstract] [Full Text] [Related]
18. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads. Xu J, Tao LL, Ma LX. J Med Virol; 2019 Dec 11; 91(12):2153-2157. PubMed ID: 31397488 [Abstract] [Full Text] [Related]
19. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Chan KA, Chang MH, Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study), Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV PreMIT Study. Hepatology; 2015 Aug 11; 62(2):375-86. PubMed ID: 25851052 [Abstract] [Full Text] [Related]
20. Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy. Zeng J, Zheng C, Li H. Medicine (Baltimore); 2019 Apr 11; 98(14):e15092. PubMed ID: 30946367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]